SCHEMBL24074427

SCHEMBL24074427

CNC(=O)Oc1ccccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.52
▸ ALDH1A1 P00352 7/20 0.52
▸ RAB9A P51151 6/20 0.52
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ MAPK1 P28482 3/20 0.52
▸ LMNA P02545 2/20 0.52
▸ PKM P14618 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ TSHR P16473 2/20 0.52
▸ STAT3 P40763 2/20 0.52
▸ PTGS1 P23219 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ MLNR O43193 1/20 0.52
▸ NR1I2 O75469 1/20 0.52
▸ ABCB11 O95342 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ ADRB2 P07550 1/20 0.52
▸ CHRM2 P08172 1/20 0.52
▸ ADRB1 P08588 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13044208 0.88 ALDH1A1 (0.65) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL24074428 0.87 NPC1 (0.53) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL26357857 0.86 NPC1 (0.54) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL13045038 0.86 RAB9A (0.58) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL24072396 0.84 STAT3 (0.44) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL24072392 0.84 ALDH1A1 (0.61) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL24073805 0.83 NPC1 (0.47) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL25063039 0.81 ALDH1A1 (0.54) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL25063130 0.81 KCNK3 (0.47) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL27134415 0.80 RAB9A (0.44) NPC1ALDH1A1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 NPC1 3949/4885ALDH1A1 1427/4885RAB9A 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback